CP and cancer: In Israel, 102 adults with solid tumors under active chemotherapy and 78 controls (same age) received their second dose of the BNT162b2 vaccine at least 12 days before enrollment; at this moment 100% of controls and 90% of cancer patients were seropositive but the median titer was significantly lower in CP than in the controls [4].